These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34622460)

  • 21. Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats.
    Poasakate A; Maneesai P; Potue P; Bunbupha S; Tong-Un T; Settheetham-Ishida W; Khamseekaew J; Pakdeechote P
    Biomed Pharmacother; 2022 Feb; 146():112601. PubMed ID: 35062067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nootropic and anticholinesterase activities of Clitoria ternatea Linn. root extract: Potential treatment for cognitive decline.
    Damodaran T; Cheah PS; Murugaiyah V; Hassan Z
    Neurochem Int; 2020 Oct; 139():104785. PubMed ID: 32650028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system.
    Leenen FH; White R; Yuan B
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2410-6. PubMed ID: 11709406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
    Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
    Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carthamus Tinctorius L. extract attenuates cardiac remodeling in L-NAME-induced hypertensive rats by inhibiting the NADPH oxidase-mediated TGF-β1 and MMP-9 pathway.
    Bunbupha S; Pakdeechote P; Maneesai P; Prachaney P; Boonprom P
    Ann Anat; 2019 Mar; 222():120-128. PubMed ID: 30590121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
    Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
    Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats.
    Beyer AM; Fredrich K; Lombard JH
    Am J Hypertens; 2013 Dec; 26(12):1398-404. PubMed ID: 23934707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H; Cody RJ; Graf K; Goetze S; Kawano Y; Schnee J; Law RE; Hsueh WA
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
    Wang X; Aukland K; Iversen BM
    Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
    Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
    Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy.
    Morgan T; Aubert JF; Brunner H
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):914-20. PubMed ID: 11587158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R; Bonhomme MC; Diebold S
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
    Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
    Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of adrenotensin on cell proliferation is mediated by angiotensin II in cultured rat mesangial cells.
    Xue H; Yuan P; Zhou L; Yao T; Huang Y; Lu LM
    Acta Pharmacol Sin; 2009 Aug; 30(8):1132-7. PubMed ID: 19597528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats.
    Odigie IP; Ettarh RR; Adigun SA
    J Ethnopharmacol; 2003 Jun; 86(2-3):181-5. PubMed ID: 12738084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the Cardiac Renin-Angiotensin System in High Oxygen-Exposed Newborn Rats: Angiotensin Receptor Blockade Prevents the Developmental Programming of Cardiac Dysfunction.
    Bertagnolli M; Dios A; Béland-Bonenfant S; Gascon G; Sutherland M; Lukaszewski MA; Cloutier A; Paradis P; Schiffrin EL; Nuyt AM
    Hypertension; 2016 Apr; 67(4):774-82. PubMed ID: 26857347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.